Exozymes Inc. (EXOZ) stock
EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.31−0.68 (-17.04%)
Close on Nov 17, 2026Market cap $30.72MP/E –Yield –
Exozymes price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Exozymes's price to book ratio was 10.2× on Nov 11, 2026, against 24.8× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 10.2× | −6.9 |
| 2025 | Dec 31, 2025 | 17.0× | – |
See a number that looks wrong?